ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.08−$0.0700 (−1.69%) on the dayAs of the close; data may be delayed.
SPRY price, last 12 months
Key stats
- Previous close
- $4.15
- Open
- $4.18
- Day range
- $4.02 – $4.18
- 52-week range
- $4.02 – $13.15
- Volume
- 819.6K
- Avg volume (20 days)
- 1.5M
- Market cap
- $405.7M
Performance
1W−0.7%
1M−32.3%
3M−52.2%
6M−52.3%
YTD−65.0%
1Y−57.6%
vs S&P 500, 1Y−74.4 pts
Technicals and fundamentals
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $405.7M